Risk factors for death due to COVID-19, in the state of Acre, Brazil, 2020: a retrospective cohort study
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Original article Risk factors for death due to COVID-19, in the state of Acre, Brazil, 2020: a retrospective cohort study doi: 10.1590/S1679-49742021000300018 Patrícia Rezende do Prado¹ - orcid.org/0000-0002-3563-6602 Fernanda Raphael Escobar Gimenes² - orcid.org/0000-0002-5174-112X Marcos Venicius Malveira de Lima³ - orcid.org/0000-0002-0332-2721 Virgilio Batista do Prado4 - orcid.org/0000-0003-0394-2143 Carolina Pontes Soares1 - orcid.org/0000-0002-9897-5863 Thatiana Lameira Maciel Amaral1 - orcid.org/0000-0002-9197-5633 ¹Universidade Federal do Acre, Centro de Ciências da Saúde e do Desporto, Rio Branco, AC, Brazil ²Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto, Ribeirão Preto, SP, Brazil ³Secretaria de Estado de Saúde do Acre, Departamento de Vigilância Epidemiológica, Rio Branco, AC, Brazil 4 Secretaria de Estado de Saúde do Acre, Rio Branco, AC, Brazil Abstract Objective: To analyze risk factors for death in individuals with severe acute respiratory syndrome due to COVID-19. Methods: This was a retrospective cohort study, comprised of adult individuals with COVID-19, from March to September 2020, notified by the Epidemiological Surveillance System in the state of Acre, Brazil. Cox regression was used. Results: Among 57,700 individuals analyzed, the incidence was 2,765.4/100,000 inhabitants, and mortality was, 61.8/100,000 inhabitants. The risk factors for death were: being male (HR=1.48 -95% CI 1.25;1.76), age ≥60 years (HR=10.64 -95% CI 8.84;12.81), symptom of dyspnea (HR=4.20 -95% CI 3.44;5.12) and multimorbidity (HR=2.23 -95% CI 1.77;2.81), with emphasis on heart disease and diabetes mellitus. 'Sore throat' and 'headache' were symptoms present in mild cases of COVID-19. Conclusion: Being male, elderly, having heart disease, diabetes mellitus and dyspnea were characteristics associated with death due to COVID-19. Keywords: Severe Acute Respiratory Syndrome; Coronavirus infections; Longitudinal studies; Risk Factors; Mortality. Correspondence: Thatiana Lameira Maciel Amaral - Universidade Federal do Acre, Centro de Ciências da Saúde e do Desporto, Campus Universitário, BR 364, Km 4, Distrito Industrial, Rio Branco, AC, Brazil. CEP: 69920-900 Postcode: 500 E-mail: thatianalameira27@gmail.com Epidemiol. Serv. Saude, Brasília, 30(3):e2020676, 2021 1
Risk factors for death due to COVID-19 Introduction The aim of this research was to analyze the epidemiological characteristics and risk factors for Severe acute respiratory syndrome (SARS) due to death in individuals with SARS due to COVID-19 in the COVID-19 (SARS due to COVID-19) is a viral respiratory state of Acre, Brazil, in 2020. disease caused by a newly discovered coronavirus. It was identified in Wuhan, Hubei Province, China, in December Methods 2019.1 The novel coronavirus has high transmissibility and can cause severe acute respiratory syndrome and This was a retrospective longitudinal cohort study. deaths. At the end of September, 2020, more than 32.7 Acre is located in the northern region of the country, million COVID-19 cases and more than 1 million deaths in the Western Brazilian Amazon, borders Peru and had been confirmed worldwide. The American Continent Bolivia, and had an estimated population of 881,935 was the hardest hit, with a number of cases exceeding people on July 1, 2019.5 The state has 380 health 16.2 million. Brazil was the second worst affected facilities, including centers and hospitals, distributed country by COVID-19 in the Americas, with 4.8 million among 22 municipalities.6 confirmed cases and more than 143 million deaths.2 The study included all COVID-19 cases reported in Acre by September 1, 2020. The first COVID-19 notification, in the state, occurred on March 15, 2020, A lot of research is being conducted with the reported symptoms having started the day in the search for practices based on before; the last case included in the study presented scientific evidence. It is fundamental to the first symptoms four days before notification, on contribute with epidemiological studies September 1, 2020. The time-zero of the cohort was aimed at health promotion, disease defined by the date of onset of symptoms, and delta- time (∆T) corresponded to the time between the date prevention and hospital care planning, of symptom onset and outcome (cure or death) for with identification of individuals cases with diagnostic confirmation of SARS due to subject to risk factors for mortality. COVID-19. The follow-up time was 60 days, started from the date of the first symptoms. The pandemic has dramatically affected health Every case of SARS is compulsorily notified and typed services. Many studies have been conducted in the individually on the Influenza Surveillance Information quest for practices based on scientific evidence. It is System (SIVEP-Gripe), whose data were used on this essential to contribute to epidemiological studies aimed notification system. On January 30, 2020, SARS due to at health promotion, disease prevention and health COVID-19 was declared as a public health emergency of care planning, with the identification of individuals international concern, by WHO, therefore the Ministry subjected to risk factors for mortality.3 of Health, through Technical Note No. 20/2020-SAPS/ In this scenario, some risk factors for mortality GAB/MS, made it compulsory to notify cases in order associated with SARS due to COVID-19 have been to enable longitudinal epidemiological investigation suggested, such as severe lymphopenia, high levels of and formulation of health policies and strategies. This C-reactive protein (correlated with severe hypoxemia), was the objective of this research.7 older age(≥60 years), male gender, race/skin color The diagnosis of COVID-19 was performed through (non-white), lower socioeconomic level, presence of laboratory tests such as, molecular test (RT-PCR) or comorbidities (e.g., diabetes mellitus, cardiovascular immunological test. diseases, hypertension and cancer, presence of fever, SARS was defined by the concomitant presence dyspnea, cough and immunocompromised status), as of four criteria: (i) fever, even if self-reported, (ii) well as obesity and unhealthy lifestyle.4 However, such cough or sore throat, (iii) dyspnea or O2 saturation factors may change depending on the characteristics
Patrícia Rezende do Prado et al. the public or private sector, throughout the national was used to analyze the continuous variables; and territory and according to the current legislation, categorical variables were described using absolute issued within 24 hours. (n) and relative (%) frequency. Pearson's chi-square The notification form of the e-SUS Epidemiological test and/or Fisher's exact test were used to compare Surveillance (e-SUS VE) contains the following independent variables with less than five occurrences. information related to individuals: notification number; Risk factors for death were analyzed using Cox Federative Unit and notifying municipality; Individual regression to estimate hazard ratio (HR) and their Taxpayer Registration Number (CPF); whether the respective 95% confidence intervals (95%CI). individual who was notified is a foreigner, health Multivariate analysis was performed using the variables professional or public security professional; date of that presented p
Risk factors for death due to COVID-19 Table 1 – Characterization of the individuals who got tested for COVID-19 (N=57,700) according to test results, notified, Acre, Brazil 2020 Total Positive Negative Variable p-valuea N N % N % Sexb Male 26,296 11,342 46.5 14,954 45.0
Patrícia Rezende do Prado et al. Continuation Table 2 – Distribution of COVID-19 cases (n=24,389) according to municipality of residence, signs and symptoms, and presence of multimorbidity, Acre, Brazil, 2020 Variable N % Multimorbidity Yes 1,492 5.9 Heart disease 834 3.3 Diabetes mellitus 443 1.7 Chronic respiratory disease 186 0.7 Reported Morbidities Chronic kidney disease 103 0.7 Immunosuppression 173 0.7 Chromosomal disorder 61 0.2 High-risk pregnancy 63 0.2 Table 3 – Distribution of SARSa cases due to COVID-19 (n=18,987) according to epidemiological, clinical and occurrence of death outcome due to the disease, Acre, Brazil, 2020 Total Death Variable p-valueb N N % Sexc Male 8,905 333 3.7
Risk factors for death due to COVID-19 Table 4 – Risk factors for death due to COVID-19a, Acre, Brazil, 2020 Adjustede Variable Crude HRb 95%ICc p-valued 95%ICc p-valued HRb Sex Male 1.78 1.49;2.11
Patrícia Rezende do Prado et al. male, 60 years of age or older, dyspnea, presence of ICU and may progress to acute respiratory distress multimorbidity, especially diabetes mellitus and heart syndrome (ARDS), with high mortality.4 In Rio Branco, diseases; among the symptoms and signs related to better the prevalence of body mass index (BMI) above 25 kg/ prognosis, the presence of sore throat and headache, as m² is 48.4% among individuals aged 18 to 39 years, and well as being a health professional stood out. 62.1% in the age group 40 to 59 years,15 which also The pandemic began in Acre in mid-March 2020. At puts the younger population at risk, given that adipose that moment, the emergence of COVID-19 in the state, tissue serves as a reservoir for the virus.16 represented an advantage for Acre by allowing more time It has been shown that health professionals, to plan a regional Public Health response. In addition, especially nursing technicians, physicians and nurses the city of Rio Branco has a specialized infectious disease are at greater risk of contracting COVID-19 because laboratory, which allowed the identification of cases at they are at the forefront of health actions in the face the beginning of the pandemic. Isolation measures, such of the pandemic. These professionals in their daily as suspension of classes and restriction on non-essential work, risk their lives to save patients with SARS due activities, were also implemented early, in order to to COVID-19, despite physical and mental exhaustion, reduce the impact on the health system. However, these the concern and agony of having to make difficult advantages and measures taken did not fully stop the decisions about patient screening process in health spread of the disease, and deaths were inevitable. care services, the grief of losing patients, colleagues, In this study, the profile of infected individuals shows friends, and also, the fear of transmitting the infection that those at productive age are at higher risk of infection. to their families. The lack of personal protective However, the higher mortality observed in individuals equipment (PPE) is also a concern17 and, despite the aged 60 years or older corroborates the data obtained high infection rate, this study did not find an increased in a study with 1,808 COVID 19 cases in the city of Rio de risk of mortality among health professionals. As if this Janeiro, state capital of Rio de Janeiro, where, according were not enough, the high viral load in the most severe to the researchers involved, people aged 30 to 59 years cases, puts the professionals responsible for their were more frequent among the cases, while individuals care, among the groups at higher risk of infection,4 aged 60 to 89 years had a higher mortality rate.8 in addition to the asymptomatic and presymptomatic Data from SouthKorea9 and Germany,10 in turn, transmission that accounted for, respectively, 51.7%18 showed a high incidence in the second decade of and 44.0%19 of the new infections. life, an aspect to be considered equally, given that the Regarding symptomatic people, the main symptoms German study suggested that this age group has played observed were: fever and cough; sore throat and an important role in the spread of the epidemic, even dyspnea were also present among them. These findings after the implementation of social distancing measures. corroborate a review of 65 articles, according to In Italy, among Intensive Care Unit (ICU) cases, a mean which, other symptoms such as headache, diarrhea, age of 63 years was observed, and only 13.0% were hemoptysis and runny nose, although less frequent, less than 51 years old.11 were also identified; 20 and the most important Elderly patients with COVID-19 are more likely to predictors of COVID-19 infection, loss of smell and progress to severe disease,12 although recent studies loss of taste, were also identified in another study.21 point out that young people are not free of this Hyposmia is a prevalent symptom in individuals with condition when they are obese. A study conducted in COVID-19, being more frequent in this disease than in the United States showed that the prevalence of obesity other respiratory tract infections. It has been described was nearly 40%, while in China, this condition was as a symptom with a high positive predictive value of 6.2%.13 In France, a significant association was found coronavirus infection (88.8%) and, also, as the initial between prevalence of obesity and SARS due to severe symptom in up to 35% of the cases of the disease. It COVID-19, suggesting that obesity might be a risk factor has been associated with less severe cases,3 as revealed for severe disease progression and, consequently, a in the cohort of this study. higher risk of ICU admission.14 Among the symptoms reported, regarding Severe disease involves bilateral interstitial the presence of dyspnea, there was a statistical pneumonia, which requires ventilatory support in the difference between those who died and those who Epidemiol. Serv. Saude, Brasília, 30(3):e2020676, 2021 7
Risk factors for death due to COVID-19 survived. Dyspnea is reported in severe cases, given underreported cases. However, the use of this database that COVID-19 uses the angiotensin-converting allows to trace the profile of severe cases of SARS due to enzyme 2 (ACE2) as a receptor, which is widely COVID-19, fundamental in times of pandemic. found in lung, intestinal, kidney and blood vessel Another point to be considered is the self-report of tissues. Moreover, this process results in the release multimorbidity, which may result in underreporting of cytokines and consequent damage to pulmonary, and underestimation of the strength of association renal and cardiac tissues.21 with adverse outcomes. It should be remembered Regarding the presence of multimorbidity, it that self-report of chronic diseases is widely used, was higher among individuals who died due to and that such information was obtained by health COVID-19 in Acre. In New York, United States, a professionals. Further studies are needed to explore study conducted with 5,700 hospitalized individuals the theme, using primary data sources and having a showed that 88.0% had more than one morbidity, the longer follow-up time. Finally, the reduced number most prevalent were: hypertension (56.6%), obesity of deaths resulted in wide confidence intervals, (41.7%) and diabetes mellitus (33.8%).23 In China, requiring caution in the analysis of the data. a study conducted with 1,590 hospitalized people The long-term follow-up stands out as the strong showed that the most prevalent morbidities were point of this study, with assessment of 'cure' and hypertension and diabetes, the hazard ratio (95%CI) 'death' outcomes. In addition, the study was conducted was 1.79 (1.16;2.77) among individuals with at least in a state in the Northern region of Brazil, with a one morbidity, and 2.59 (1.61;4.17) among those with population whose laboratory diagnosis for COVID two or more morbidities.24 According to a Brazilian 19 and notification of the disease were performed study conducted in the pandemic period up to the via the e-SUS VE/SIVEP-Gripe, being followed up for 21st Epidemiological Week of 2020, diabetes was also case closure and identification of health outcomes. more prevalent in individuals hospitalized with SARS The choice of the type of study and the sample size, in due to COVID-19, compared to the general population times of pandemic, reinforces its importance, insofar of the country.25 The possible explanation for severe as work subsidizes knowledge about the reality of states conditions in people with diabetes mellitus is due to that are far from the large urban centers in the country, constant glucose recognition by C type lectin receptors, enabling the identification of regional risk factors for generating greater inflammatory response.22 death due to COVID-19. In a study with 1,139 cases and 11,390 controls Taking these results, it can be concluded that the conducted in Madrid, Spain, researchers observed that study analyzed the epidemiological characteristics and renin-angiotensin-aldosterone system inhibitors did risk factors for death in individuals diagnosed with not increase the risk of SARS due to severe COVID-19, SARS due to COVID-19 in the state of Acre. Risk groups and the discontinuity of treatment by patients was need special attention, especially the elderly, patients discouraged. Furthermore, continuous monitoring with dyspnea and those with diabetes mellitus. Some of these individuals was recommended because the symptoms were more frequent in mild cases of COVID-19 presence of cardiovascular diseases can aggravate and should be better elucidated in future studies. pneumonia and may result in unfavorable outcomes.26 Among the limitations of this study, it is worth Authors’ contributions mentioning the use of secondary data obtained from the state epidemiological surveillance, which limited Prado PR, Gimenes FRE, Lima MVM and Soares information detailing, especially about the presence or CP collaborated with the conception and design of not of hypertension. It is suggested the inclusion of the the manuscript, data analysis and interpretation and following variables: 'arterial hypertension', 'anosmia/ drafting the first version of the manuscript. Prado hyposmia/dysgeusia/ageusia', 'myalgia', 'sore throat', VB and Amaral TLM collaborated with data analysis 'headache', 'runny nose' and 'diarrhea', in the e-SUS VE and interpretation, and critical reviewing of the questionnaire, in order to better support future studies. manuscript. All authors have approved the final version Other possible limitations of the study are (i) information of the manuscript and have declared themselves to quality, dependent on the complete and correct be responsible for all aspects of the work, including completion of the e-SUS VE notification form, and (ii) ensuring its accuracy and integrity. 8 Epidemiol. Serv. Saude, Brasília, 30(3):e2020676, 2021
Patrícia Rezende do Prado et al. References 1. Li Q, Guan X, Wu P, Wang X, Zhou L, Yeqing T, et al. board.es?mid=a30402000000&bid=0030&act=view Early transmission dynamics in Wuhan, China, of &list_no=366674&tag=&nPage=6 novel coronavirus-infected pneumonia. N Engl J Med. 10. Goldstein E, Lipsitch M. Temporal rise in the 2020 Marc 26;382(13):1199-207. doi: https://doi. proportion of younger adults and older adolescents org/10.1056/NEJMo a2001 316. among coronavirus disease (Covid-19) cases 2. World Health Organization. WHO health emergency following the introduction of physical distancing dashboard: WHO Covid-19 [Internet]. Geneva: WHO: measures, Germany, March to April 2020. Euro c2020 [acesso 14 abr. 2021]. Disponível em: https:// Surveill. 2020;25(17):2000596. doi: https://doi. covid19.who.int/ org/10.2807/1560-7917.ES.2020.25.17.2000596. 3. Cowling BJ, Leung GM. Epidemiological research 11. Grasselli G, Zangrillo A, Zanella A, Antonelli M, priorities for public health control of the ongoing Cabrini L, Castelli A, et al. Baseline characteristics and global novel coronavirus (2019-nCoV) outbreak. outcomes of 1591 patients infected with SARS-CoV-2 Euro Surveill. 2020;25(6):2000110. doi: https://doi. admitted to ICUs of the Lombardy Region, Italy. JAMA. org/10.2807/1560-7917.ES.2020.25.6.2000110. 2020 Apr 28;323(16):1574-81. doi: https://doi. org/10.1001/jama.2020.5394. 4. Hamer M, Kivimäki M, Gale CR, Batty GD. Lifestyle risk factors, inflammatory mechanisms, and Covid-19 12. Rod JE, Oviedo-Trespalacios O, Cortes-Ramirez J. A hospitalization: a community-based cohort study brief-review of the risk factors for Covid-19 severity. of 387,109 adults in UK. Brain Behav Immun. Rev Saude Publica. 2020 ;54:60. doi: https://doi. 2020;87:184-187. doi: https://doi.org/10.1016/j. org/10.11606/s1518-8787.2020054002481. bbi.2020.05.059. 13. Kass DA; Duggal P; Cingolani O. Obesity could shift 5. Instituto Brasileiro de Geografia e Estatística., severe Covid-19 disease to younger ages. Lancet. Estimativas da população residente com data de 2020 May 16;395 (10236):1544-45. doi: https://doi. referência 1 de julho de 2019 [Internet]. [Brasília, org/10.1016/S0140-6736(20)31024-2. DF]: IBGE; [data desconhecida; acesso 15 maio 14. Caussy C, Pattou F, Wallet F, Simon C, Chalopin S, 2021] Disponível em: https://www.ibge.gov.br/ Telliam C, et al. Prevalence of obesity among adult cidades-e-estados/ac/.html inpatients with Covid-19 in France. Lancet Diabetes 6. Instituto Brasileiro de Geografia e Estatística. Endocrinol. 2020;8(7):562-4. doi: https://doi. Assistência médica sanitária: 2009. Rio de Janeiro: org/10.1016/S2213-8587(20)30160-1. IBGE; 2010. 15. Loureiro NSL, Amaral TLM, Amaral CA, Monteiro 7. Ministério da Saúde (BR). Nota Técnica n.20/2020- GTR, Vasconcellos MTL, Bortolini MJS. Relationship SAPS/GAB/SAPS/MS. Notificação imediata de casos between anthropometric indicators and risk factors de Síndrome Gripal via plataforma do eSUS VE for cardiovascular disease in adults and older e Síndrome Respiratória Aguda Grave (SRAG) adults of Rio Branco, Acre. Rev Saude Publica. hospitalizado no SIGEP-Gripe. Brasília, DF: MS; 2020;54:24. doi: https://doi.org/10.11606/s1518- 14 abr. 2020 [acesso 15 maio 2021] Disponível 8787.2020054001088. em: https://datasus.saude.gov.br/wp-content/ 16. Lucena TMC, Santos AFS, Lima BR, Borborema uploads/2020/04/Nota-T%C3%A9cnica-20_ MEA, Silva JA. Mechanism of inflammatory response Notifica%C3%A7%C3%A3o-Imediata-de-Casos-de- in associated comorbidities in Covid-19. Diabetes S%C3%ADndrome-Gripal-via-plataforma-do-eSUS- Metab Syndr. 2020;14(4):597-600. doi: https://doi. VE-e-S%C3%ADndrome-Respirat%C3%B3ria-Aguda- org/10.1016/j.dsx.2020.05.025. Grave-SRAG-hospitalizado-no-SIVEP-Gripe..pdf 17. Lancet. COVID-19: protecting health-care workers. 8. Cavalcante JR, Abreu AJL. Covid-19 no município do Lancet. 2020 Mar 21;395(10228):922. doi: https:// Rio de Janeiro: análise espacial da ocorrência dos doi.org/10.1016/S0140-6736(20)30644-9. primeiros casos e óbitos confirmados. Epidemiol Serv Saude. 2020; 29(3):e2020204. doi: http://dx.doi. 18. Mizumoto K, Kagaya K, Zarebski A, Chowell org/10.5123/s1679-49742020000300007. G. Estimating the asymptomatic proportion of coronavirus disease 2019 (Covid-19) cases on 9. Korea Center for Disease Control (KCDC). The board the Diamond Princess cruise ship, Yokohama, updates on SRAG-COVID in Korea as of 28 March Japan, 2020. Euro Surveill. 2020;25(10):2000180. [Internet]. Cheongju: KCDC; [2020] [acesso 15 maio doi: https://doi.org/10.2807/1560-7917. 2021]. Disponível em: https://www.cdc.go.kr/board/ ES.2020.25.10.2000180. Epidemiol. Serv. Saude, Brasília, 30(3):e2020676, 2021 9
Risk factors for death due to COVID-19 19. He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, 5700 patients hospitalized with Covid-19 in the New et al. Temporal dynamics in viral shedding York City Area. JAMA. 2020 May 26;323(20):2052-9. and transmissibility of Covid-19. Nat Med. doi: https://doi.org/10.1001/jama.2020.6775. 2020;26(5):672-5. doi: https://doi.org/10.1038/ 24. Guan WJ, Liang W-H, Zhao Y, Liang H-R, Chen Z-S, s41591-020-0869-5. Li Y-M, et al. Comorbidity and its impact on 1590 20. Liu K, Chen Y, Lin R, Han K. Clinical features of patients with Covid-19 in China: a nationwide analysis. Covid-19 in elderly patients: a comparison with young Eur Respir J. 2020 May 14;55(5):2000547. doi: and middle-aged patients. J Infect. 2020;80(6):e14-8. https://doi.org/10.1183/13993003.00547-2020. doi: https://doi.org/10.1016/j.jinf.2020.03.005. 25. Niquini RP, Lana RM, Pacheco AG, Cruz OG, Coelho 21. Printza A, Constantinidis J. The role of self-reported FC, Carvalho LM, et al. Description and comparison smell and taste disorders in suspected Covid-19.. Eur of demographic characteristics and comorbidities Arch Otorhinolaryngol. 2020;277(9):2625-30. doi: in SARI from Covid-19, SARI from influenza, https://doi.org/10.1007/s00405-020-06069-6. and the Brazilian general populstion Cad Saude Publica. 2020;36(7):e00149420. doi: https://doi. 22. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger org/10.1590/0102-311x00149420. N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a 26. Abajo FJ, Rodríguez-Martín S, Lerma V, Mejía- clinically proven protease inhibitor. Cell. 2020 Apr Abril G, Aguilar M, García-Luque A, et al. Use of 16;181(2):271-80.e8. doi: https://doi.org/10.1016/j. renin–angiotensin–aldosterone system inhibitors cell.2020.02.052. and risk of Covid-19 requiring admission to hospital: a case-population study. Lancet. 2020 23. Richardson S, Hirsch JS, Narasimhan M, Crawford May 30;395(10238):1705-14. doi: https://doi. JM, McGinn T, Davidson KW, et al. Presenting org/10.1016/S0140-6736(20)31030. characteristics, comorbidities, and outcomes among Received on 26/08/2020 Approved on 09/03/2021 Associate Editor: Bruno Pereira Nunes - orcid.org/0000-0002-4496-4122 Scientific Editor: Taís Freire Galvão - orcid.org/0000-0003-2072-4834 Editor-in-chief: Leila Posenato Garcia - orcid.org/0000-0003-1146-2641 10 Epidemiol. Serv. Saude, Brasília, 30(3):e2020676, 2021
You can also read